D-Wave Quantum: A $100 Million Grant and Record Orders Dwarf a Revenue Sag Ahead of Investor Day

Despite an 81% revenue drop to $2.9M, D-Wave posts record $33.4M in orders and secures a $100M CHIPS Act grant. Stock surges 58% in 30 days, with 14 of 17 analysts rating Buy.

D-Wave Quantum heads into its first-ever Investor Day on Sunday with an unusual mix of signals. On one hand, the company’s quarterly revenue collapsed 81% to just $2.9 million, stripped of a large system sale that had boosted the prior-year figure. On the other, new orders hit a record $33.4 million — a near-2,000% leap — underpinned by a $20 million system sale to Florida Atlantic University and a $10 million cloud-services contract with a Fortune 100 firm. The order book suggests commercial momentum is building even as top-line numbers churn.

That divergence helps explain why the market cheered a $100 million grant commitment from the U.S. Commerce Department under the CHIPS and Science Act. Announced on May 21, the memorandum of understanding gives D-Wave access to federal funding for developing superconducting annealing and gate-model systems. In exchange, the government will take a minority equity stake — a strategic shift in Washington’s approach to technology support that effectively makes the state a shareholder in quantum’s future.

Shares closed the Thursday after the announcement at €25.30, up 7% on the day, with 54 million shares changing hands — 69% above the average daily volume. The rally pushed the market cap near $11 billion, though the stock has since eased to around €24.71. Even so, the 30-day gain stands at nearly 58%, and from the 52-week low of €11.32 set in March, the price has more than doubled. Midweek, the stock had suffered a sharp 10% intraday drop on profit-taking and reports questioning D-Wave’s computational-supremacy claims, which the company rebutted as inaccurate. The recovery was swift.

Wall Street remains largely constructive. Among 17 analysts covering D-Wave, 14 rate it a Buy, two a Hold, and one a Sell. The consensus 12-month price target hovers around $34, though a narrower poll of 13 analysts sees an average of $35.17, with a high estimate of $45. Mizuho recently trimmed its target to $29 but kept an Outperform call, while Rosenblatt Securities stands at $43. At a market capitalization of roughly $10.3 billion, the stock trades at about 243 times expected revenue for this year — a bet that the sales trajectory will eventually catch up.

The company enters Sunday’s event with a well-stocked treasury: $588.4 million in cash. That cushion, combined with the federal grant, underwrites a dual-platform strategy built on established annealing systems and the pursuit of fault-tolerant gate-model computers. The acquisition of Quantum Circuits targets a first 17 dual-rail qubit system by the end of 2026, with a stretch goal of 100 logical qubits by 2032. The Investor Day, running from 1:00 to 4:00 p.m. ET at the New York Stock Exchange under the banner “The D?Wave Difference,” will detail the technology roadmap, commercial progress, and financial strategy. Management has already hit the conference circuit hard, appearing at TD Cowen, Needham, J.P. Morgan, and Canaccord, with shows at Baird and Rosenblatt slated for early June.

A follow-up event, Qubits Europe 2026, is scheduled for June 18 in London, featuring real-world use cases from the UK, Germany, Italy, and North America. Between the federal windfall, the record order book, and the scrutiny of an investor day that will test whether valuation can be justified by concrete milestones, D-Wave is squeezing months of narrative into a single week.